ROGELYN HARLAN: Open Payments
NPI 1568715399 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 5 payments from 5 companies in 2025. Trend: 2023 $122 · 2024 $319 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $146 |
| AstraZeneca Pharmaceuticals LP | 1 | $128 |
| GENZYME CORPORATION | 1 | $125 |
| Amgen Inc. | 1 | $122 |
| Janssen Scientific Affairs, LLC | 1 | $27 |
Products named: RYBREVANT, IMDELLTRA (AMG757), DARZALEX.
Industry payments across OR — which companies pay providers there.
